{
  "id": "kawasaki_aspirin_multipleChoice_v1",
  "type": "multipleChoice",
  "stem": "A child is diagnosed with Kawasaki Disease and is prescribed high-dose aspirin and intravenous immunoglobulin (IVIG). The parents ask the nurse why the child needs aspirin, given the known risk of Reye Syndrome. What is the nurse's best response?",
  "options": [
    {
      "id": "a",
      "text": "Aspirin is the only medication that can lower the high-grade fever associated with this disease."
    },
    {
      "id": "b",
      "text": "The primary purpose of aspirin in this condition is to prevent coronary artery aneurysms and blood clots."
    },
    {
      "id": "c",
      "text": "The intravenous immunoglobulin (IVIG) therapy completely eliminates the risk of Reye Syndrome."
    },
    {
      "id": "d",
      "text": "The child will only receive one dose of aspirin to minimize any potential toxic effects."
    }
  ],
  "correctOptionId": "b",
  "pedagogy": {
    "bloomLevel": "apply",
    "cjmmStep": "generateSolutions",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 4,
    "topicTags": [
      "Kawasaki Disease",
      "Aspirin",
      "Pediatrics",
      "Pharmacology",
      "Cardiology"
    ]
  },
  "upgradedRationale": {
    "answerBreakdown": [
      {
        "optionId": "a",
        "content": "Incorrect. While aspirin does have antipyretic properties, it is not the only medication that can lower fever. The primary reason for using aspirin in Kawasaki Disease is its anti-inflammatory and antiplatelet effects to prevent coronary artery complications. Other antipyretics can be used for fever management."
      },
      {
        "optionId": "b",
        "content": "Correct. Kawasaki Disease causes inflammation of the blood vessels, particularly the coronary arteries. Aspirin helps to prevent blood clots and the formation of coronary artery aneurysms, which are serious complications of this disease. The anti-inflammatory and antiplatelet effects are crucial in preventing long-term cardiac damage."
      },
      {
        "optionId": "c",
        "content": "Incorrect. IVIG helps to reduce inflammation and the risk of coronary artery abnormalities, but it does not eliminate the risk of Reye Syndrome. Reye Syndrome is a rare but serious condition associated with aspirin use, especially during viral illnesses. The benefits of aspirin outweigh the risk in this specific case."
      },
      {
        "optionId": "d",
        "content": "Incorrect. The child will receive high-dose aspirin initially to reduce inflammation, followed by a lower dose for an extended period to prevent blood clots. The duration of aspirin therapy depends on the presence of coronary artery abnormalities. The treatment is multi-phased and requires careful monitoring."
      }
    ],
    "questionTrap": "The primary trap is the absolute contraindication of aspirin in children. Test-takers must recognize that Kawasaki Disease is one of the very few, specific exceptions to this rule. The benefit of preventing life-threatening coronary artery aneurysms far outweighs the risk of Reye Syndrome in this clinical context. The question requires prioritizing the specific disease pathophysiology over a general pediatric safety rule.",
    "mnemonics": "For Kawasaki symptoms, use **CRASH & BURN**:\n*   **C**onjunctivitis (bilateral, non-exudative)\n*   **R**ash (polymorphous)\n*   **A**denopathy (cervical, unilateral)\n*   **S**trawberry tongue / mucous membrane changes\n*   **H**ands and feet (edema, erythema)\n*   **BURN** (Fever > 5 days, high and unresponsive to typical antipyretics)\n\nTreatment: **ASA & IVIG to save the heart.**"
  },
  "scoring": {
    "method": "dichotomous",
    "maxPoints": 1
  },
  "module": "Pediatrics",
  "learningObjective": "Evaluate the pharmacological interventions for Kawasaki Disease, including the rationale for aspirin therapy despite the risk of Reye Syndrome.",
  "competency": "Pharmacological and Parenteral Therapies",
  "clientNeed": "Pharmacological and Parenteral Therapies",
  "safeEffectiveCareEnvironment": "Medication Administration",
  "managementOfCare": "Implementing Provider's Orders",
  "safetyAndInfectionControl": "Standard Precautions",
  "healthPromotionAndMaintenance": "Growth and Development",
  "psychosocialIntegrity": "Support Systems",
  "physiologicalAdaptation": "Alterations in Body Systems",
  "priorityConcepts": [
    "Pharmacology",
    "Inflammation",
    "Cardiovascular",
    "Immunity"
  ],
  "setting": "Inpatient Pediatric Unit",
  "clinicalArea": "Cardiology",
  "timeToAnswer": 90,
  "rationales": {
    "a": "Incorrect. While aspirin does have antipyretic properties, it is not the only medication that can lower fever. The primary reason for using aspirin in Kawasaki Disease is its anti-inflammatory and antiplatelet effects to prevent coronary artery complications.",
    "b": "Correct. Kawasaki Disease causes inflammation of the blood vessels, particularly the coronary arteries. Aspirin helps to prevent blood clots and the formation of coronary artery aneurysms, which are serious complications of this disease.",
    "c": "Incorrect. IVIG helps to reduce inflammation and the risk of coronary artery abnormalities, but it does not eliminate the risk of Reye Syndrome. Reye Syndrome is a rare but serious condition associated with aspirin use, especially during viral illnesses.",
    "d": "Incorrect. The child will receive high-dose aspirin initially to reduce inflammation, followed by a lower dose for an extended period to prevent blood clots. The duration of aspirin therapy depends on the presence of coronary artery abnormalities."
  },
  "clinicalPearls": [
    "Kawasaki Disease is a systemic vasculitis that primarily affects children and can lead to serious cardiac complications if left untreated.",
    "Aspirin is used in Kawasaki Disease for its anti-inflammatory and antiplatelet effects, despite the risk of Reye Syndrome.",
    "The treatment for Kawasaki Disease typically involves high-dose aspirin and IVIG.",
    "Monitor for signs and symptoms of coronary artery aneurysms, such as chest pain or shortness of breath.",
    "Educate parents about the importance of adhering to the prescribed aspirin regimen and reporting any signs of viral illness."
  ],
  "sbar": {
    "situation": "1400: Child admitted with Kawasaki Disease, prescribed high-dose aspirin and IVIG.",
    "background": "Kawasaki Disease is a systemic vasculitis, posing risk of coronary artery aneurysms. Aspirin is crucial to prevent clots and reduce inflammation. Patient has no known allergies.",
    "assessment": "Parents express concern about Reye Syndrome risk with aspirin. Vital signs stable: HR 120, RR 24, Temp 38.5°C, BP 100/60. No signs of bleeding.",
    "recommendation": "Educate parents on aspirin's benefits in preventing cardiac complications, despite Reye Syndrome risk. Emphasize close monitoring for viral illness signs. Consult physician if concerns persist. Continue scheduled aspirin and IVIG administration as prescribed."
  },
  "references": [
    "Burns, J. C., & Glodé, M. P. (2004). Kawasaki syndrome. The Lancet, 364(9433), 533-544.",
    "Newburger, J. W., Takahashi, M., Burns, J. C., Beiser, A. S., Chung, K. J., Colan, S. D., ... & Wiggins, J. W. (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 110(17), 2747-2771."
  ],
  "nclex": {
    "clientNeed": "Pharmacological and Parenteral Therapies",
    "contentArea": "Pharmacology",
    "cognitiveLevel": "Apply"
  },
  "keywords": [
    "Kawasaki Disease",
    "Aspirin",
    "IVIG",
    "Reye Syndrome",
    "Coronary Artery Aneurysm",
    "Pediatrics",
    "Vasculitis"
  ],
  "creationDate": "2024-01-01",
  "lastUpdated": "2024-07-26",
  "sentinelStatus": "healed_v2026_v11",
  "rationale": {
    "correct": "Aspirin's primary role in Kawasaki Disease is to prevent coronary artery aneurysms and blood clots by reducing inflammation and inhibiting platelet aggregation. This outweighs the risk of Reye Syndrome in this specific clinical context."
  }
}